The Biden administration is facing serious accusations from FDA Commissioner Marty Makary regarding the handling of myocarditis data related to the COVID vaccine. Makary claims that important information about risks, especially for young people, was not released to the public. He stated in an NBC News interview, “We found that the Biden administration was sitting on data on myocarditis in young people, and it was not made public.”
Makary’s comments followed a memo from Vinay Prasad, an FDA official, who revealed that at least 10 children reportedly died after receiving the COVID vaccine. He hinted at a connection to myocarditis, although he did not provide evidence to back that statement.
Myocarditis, which is inflammation of the heart muscle, has been identified as a rare side effect of the mRNA COVID vaccines from Pfizer and Moderna. This risk has been acknowledged by health officials since 2021. Symptoms of myocarditis can include shortness of breath, chest pain, and a racing heart.
In 2021, the CDC began monitoring reports of heart inflammation, especially among young people. In June of that year, their advisory panel identified a “likely association” between the vaccines and myocarditis but concluded that the benefits of vaccination still outweighed the risks.
In response to Makary’s assertions, some former FDA officials pushed back hard, arguing that there has been transparency throughout the process. A senior health official called the claim “absurd,” while Dr. Ofer Levy from Boston Children’s Hospital pointed out that data about myocarditis had been shared publicly.
He remarked, “There was no secret information or cover-up. We were broadcasting in real-time, with public commentary.” This highlights the ongoing debate over vaccine safety and the importance of public trust in health agencies.
Makary suggests that new findings are pending concerning child deaths, claiming his team is reviewing family reports and autopsies. However, he has remained vague on crucial details, such as the ages and medical histories of the children involved.
Statistics reveal that the risk of myocarditis appears to be highest in males aged 12 to 29, particularly after the second vaccine dose. A 2021 CDC report indicated a rate of 40.6 cases per million second doses for males in that age group, contrasting with just 2.4 cases per million for older males.
Most cases of myocarditis linked to vaccines are mild and resolve quickly. Moreover, COVID-19 infection itself poses a greater risk for myocarditis than the vaccines. As of now, no confirmed deaths have been linked to myocarditis from the COVID shots.
In summary, the interplay between vaccine safety claims and public health messaging remains a topic of intense scrutiny and debate, intensifying the need for clear and accurate communication from health officials.
Source link
